Guided Therapeutics, Inc.

GTHP · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$742-$809-$427-$652
Dep. & Amort.$27$27$25$24
Deferred Tax$0$0$0$0
Stock-Based Comp.$22$311$19-$13
Change in WC-$287$273$14$275
Other Non-Cash$703$29$38$34
Operating Cash Flow-$277-$169-$331-$332
Investing Activities
PP&E Inv.-$2$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$2$0$0$0
Financing Activities
Debt Repay.$0$239-$147-$9
Stock Issued-$205$0$205$535
Stock Repurch.$0$0$0$0
Dividends Paid$0$0-$36$87
Other Fin. Act.$217$0$36$135
Financing Cash Flow$181$239$58$526
Forex Effect$0$0$0$0
Net Chg. in Cash-$98$70-$273$194
Supplemental Information
Beg. Cash$185$115$388$194
End Cash$87$185$115$388
Free Cash Flow-$279-$169-$331-$332